CD33 and acute myeloid leukemia: In addition, a dual aptamer targeting CD33 and CD34 has been screened by cell-SELEX process, and can be used for leukemic cell detection or drug delivery using gold functionalized nanoparticles containing AML-M2 overexpressed gene-targeting ASOs, such as Bcl-2 or XIAP [61].